Skip to Content
Merck
  • Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer.

Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer.

Nature communications (2022-02-19)
Misty Shuo Zhang, Jane Di Cui, Derek Lee, Vincent Wai-Hin Yuen, David Kung-Chun Chiu, Chi Ching Goh, Jacinth Wing-Sum Cheu, Aki Pui-Wah Tse, Macus Hao-Ran Bao, Bowie Po Yee Wong, Carrie Yiling Chen, Chun-Ming Wong, Irene Oi-Lin Ng, Carmen Chak-Lui Wong
ABSTRACT

Hepatocellular carcinoma (HCC) invariably exhibits inadequate O2 (hypoxia) and nutrient supply. Hypoxia-inducible factor (HIF) mediates cascades of molecular events that enable cancer cells to adapt and propagate. Macropinocytosis is an endocytic process initiated by membrane ruffling, causing the engulfment of extracellular fluids (proteins), protein digestion and subsequent incorporation into the biomass. We show that macropinocytosis occurs universally in HCC under hypoxia. HIF-1 activates the transcription of a membrane ruffling protein, EH domain-containing protein 2 (EHD2), to initiate macropinocytosis. Knockout of HIF-1 or EHD2 represses hypoxia-induced macropinocytosis and prevents hypoxic HCC cells from scavenging protein that support cell growth. Germline or somatic deletion of Ehd2 suppresses macropinocytosis and HCC development in mice. Intriguingly, EHD2 is overexpressed in HCC. Consistently, HIF-1 or macropinocytosis inhibitor suppresses macropinocytosis and HCC development. Thus, we show that hypoxia induces macropinocytosis through the HIF/EHD2 pathway in HCC cells, harnessing extracellular protein as a nutrient to survive.

MATERIALS
Product Number
Brand
Product Description

Roche
Cell Proliferation Kit II (XTT), liquid, pkg of 1 kit, suitable for cell analysis, suitable for tissue culture
Sigma-Aldrich
Bafilomycin A1
Sigma-Aldrich
VH298, ≥98% (HPLC)
Sigma-Aldrich
IPA-3, ≥95% (HPLC), powder
Roche
Cell Proliferation ELISA, BrdU (colorimetric), sufficient for ≤1,000 tests